JP2020518668A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020518668A5 JP2020518668A5 JP2020511734A JP2020511734A JP2020518668A5 JP 2020518668 A5 JP2020518668 A5 JP 2020518668A5 JP 2020511734 A JP2020511734 A JP 2020511734A JP 2020511734 A JP2020511734 A JP 2020511734A JP 2020518668 A5 JP2020518668 A5 JP 2020518668A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- seq
- amino acid
- acid sequence
- antibody fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 26
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 25
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 9
- 206010006187 Breast cancer Diseases 0.000 claims description 2
- 208000026310 Breast neoplasm Diseases 0.000 claims description 2
- 206010008342 Cervix carcinoma Diseases 0.000 claims description 2
- 206010017993 Gastrointestinal neoplasms Diseases 0.000 claims description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 2
- 206010033128 Ovarian cancer Diseases 0.000 claims description 2
- 206010061535 Ovarian neoplasm Diseases 0.000 claims description 2
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 claims description 2
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims description 2
- 208000002495 Uterine Neoplasms Diseases 0.000 claims description 2
- 201000010881 cervical cancer Diseases 0.000 claims description 2
- 206010017758 gastric cancer Diseases 0.000 claims description 2
- 201000005202 lung cancer Diseases 0.000 claims description 2
- 208000020816 lung neoplasm Diseases 0.000 claims description 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims description 2
- 201000002528 pancreatic cancer Diseases 0.000 claims description 2
- 208000008443 pancreatic carcinoma Diseases 0.000 claims description 2
- 210000000664 rectum Anatomy 0.000 claims description 2
- 201000011549 stomach cancer Diseases 0.000 claims description 2
- 206010046766 uterine cancer Diseases 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 241001529936 Murinae Species 0.000 claims 1
- 208000015634 Rectal Neoplasms Diseases 0.000 claims 1
- 230000000112 colonic effect Effects 0.000 claims 1
- 206010038038 rectal cancer Diseases 0.000 claims 1
- 201000001275 rectum cancer Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762492912P | 2017-05-01 | 2017-05-01 | |
| US62/492,912 | 2017-05-01 | ||
| PCT/US2018/030276 WO2018204278A1 (en) | 2017-05-01 | 2018-04-30 | COMPOSITIONS AND METHODS RELATED TO xCT ANTIBODIES |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020518668A JP2020518668A (ja) | 2020-06-25 |
| JP2020518668A5 true JP2020518668A5 (cg-RX-API-DMAC7.html) | 2020-10-15 |
Family
ID=64016266
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020511734A Pending JP2020518668A (ja) | 2017-05-01 | 2018-04-30 | ｘＣＴ抗体に関連する組成物および方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11059901B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3618869A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2020518668A (cg-RX-API-DMAC7.html) |
| CN (1) | CN111194222A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2018261720A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3060590A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018204278A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12014835B2 (en) | 2020-02-19 | 2024-06-18 | Vanderbilt University | Methods for evaluating therapeutic benefit of combination therapies |
| WO2021168283A1 (en) * | 2020-02-19 | 2021-08-26 | Vanderbilt University | Therapeutic methods and compositions for treating cancer using braf and/or mek inhibitor combination therapy |
| JP2024542030A (ja) | 2021-10-29 | 2024-11-13 | ブイアイビー ブイゼットダブリュ | 慢性創傷治癒のための手段および方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2329851T3 (es) | 1998-06-01 | 2009-12-01 | Agensys, Inc. | Nuevos antigenos transmembranables expresados en canceres humano y utilizacion de los mismos. |
| NZ535925A (en) | 2002-04-16 | 2008-06-30 | Genentech Inc | An isolated antibody that binds to a particular polypeptide |
| WO2003101388A2 (en) * | 2002-05-30 | 2003-12-11 | Bristol-Myers Squibb Company | Human solute carrier family 7 member 11 (hslc7a11) |
| EP2239577A1 (en) * | 2009-04-07 | 2010-10-13 | Vereniging voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek en Patiëntenzorg | Protein-based methods and compositions for the diagnosis of colorectal adenocarcinoma |
| CN102719521B (zh) * | 2011-03-31 | 2015-12-02 | 上海市肿瘤研究所 | 胱氨酸/谷氨酸反向转体xCT抑制剂在肝癌治疗中的应用 |
| US10584161B2 (en) * | 2015-09-21 | 2020-03-10 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Monoclonal antibodies specific for heartland virus and methods of their use |
| WO2017106806A1 (en) * | 2015-12-18 | 2017-06-22 | Federica Cavallo | COMPOSITIONS AND METHODS RELATED TO xCT PEPTIDES |
| CN105837686B (zh) * | 2016-05-27 | 2020-08-28 | 洛阳普泰生物技术有限公司 | 一种单克隆抗体及其应用 |
-
2018
- 2018-04-30 EP EP18794274.3A patent/EP3618869A4/en not_active Withdrawn
- 2018-04-30 JP JP2020511734A patent/JP2020518668A/ja active Pending
- 2018-04-30 WO PCT/US2018/030276 patent/WO2018204278A1/en not_active Ceased
- 2018-04-30 CA CA3060590A patent/CA3060590A1/en not_active Abandoned
- 2018-04-30 US US16/609,704 patent/US11059901B2/en not_active Expired - Fee Related
- 2018-04-30 AU AU2018261720A patent/AU2018261720A1/en not_active Abandoned
- 2018-04-30 CN CN201880028741.7A patent/CN111194222A/zh active Pending